EMERGENCY:Post-cardiac arrest with return of spontaneous circulation (ROSC) —call040-46324365immediately — 24 hours, 7 days— 24/7
Hypoxic Brain Injury — Specialist Neurointensive Care in Hyderabad at KIMS
Hypoxic brain injury occurs when the brain receives significantly reduced but not completely absent oxygen delivery for a period sufficient to cause neuronal injury. It is the most common form of acquired brain injury after cardiac arrest, and it is also seen after severe respiratory failure, near-drowning, carbon monoxide poisoning, and prolonged severe hypotension. The word "hypoxic" distinguishes it from "anoxic" (complete absence of oxygen) — although in practice the two terms are often used interchangeably, and the distinction matters more for prognosis than for acute management.
Hypoxic brain injury occurs when the brain receives significantly reduced (but not completely absent) oxygen for a period sufficient to cause neuronal injury. It is the most common ABI after cardiac arrest with return of spontaneous circulation (ROSC), and also follows severe respiratory failure, near-drowning, CO poisoning, and prolonged hypotension. The paradox of hypoxic brain injury is reperfusion injury: when blood flow is restored after ROSC, the sudden return of oxygen reacts with accumulated free radicals to form reactive oxygen species, excitotoxicity (glutamate surge) overwhelms neurons, calcium floods cells, and mitochondria fail — producing a second wave of injury potentially more damaging than the original hypoxic phase. Targeted temperature management (TTM) — cooling to 33–36°C for 24 hours after ROSC — reduces cerebral metabolic demand and suppresses this reperfusion cascade. CO poisoning: carboxyhaemoglobin binds haemoglobin with 250× greater affinity than oxygen; standard pulse oximetry is misleadingly normal (reads COHb as OHb); co-oximetry is required. Neuroprognostication is performed at 72 hours after normothermia, not before, using multiple tests simultaneously: clinical exam, EEG, SSEPs (bilateral absent N20 = high specificity for poor prognosis), NSE (>60 μg/L = poor prognosis), and MRI.
- Reperfusion injury — the second wave
- The post-ROSC period is not simply recovery — it is a critical window of secondary injury. Restored oxygenation reacts with free radicals accumulated during ischaemia → reactive oxygen species oxidise cell membranes and DNA. Glutamate floods synapses (excitotoxicity). Calcium influx activates destructive enzymes. Mitochondria release cytochrome C, triggering apoptosis in neurons that survived the original hypoxia. This reperfusion injury is the target of TTM: cooling suppresses metabolism, reduces free radical generation, and limits the inflammatory cascade.
- Targeted temperature management — how and why
- TTM: deliberate cooling of the post-ROSC patient to 33–36°C for 24 hours, then controlled rewarming (maximum 0.25°C/hour — faster rewarming causes rebound oedema), then fever prevention (no temperature above 37.5°C) for a further 48–72 hours. Each degree of fever after cardiac arrest significantly worsens neurological outcome by increasing metabolic demand and exacerbating excitotoxicity. TTM available at KIMS with surface and endovascular cooling devices.
- CO poisoning — the false-normal pulse oximetry
- Standard pulse oximetry cannot distinguish oxyhaemoglobin (red, carrying oxygen) from carboxyhaemoglobin (also red, NOT carrying oxygen). In CO poisoning, the SpO₂ reads 99–100% while the patient is severely oxygen-depleted. Diagnosis requires ABG co-oximetry. COHb >25% + coma or cardiac involvement = indication for hyperbaric oxygen (HBO). HBO dramatically accelerates CO elimination and reduces delayed neurological syndrome (DNS) risk.
- Delayed neurological syndrome (DNS) — the 2–4 week trap
- 10–30% of severe CO poisoning survivors experience apparent initial recovery followed by personality changes, memory loss, cognitive decline, parkinsonism, and incontinence appearing 2–4 WEEKS after the acute event. This DNS results from continued white matter damage (particularly globus pallidus and white matter tracts) long after CO elimination. CO brain fingerprint on MRI: bilateral globus pallidus T2 hyperintensity. Close neurological follow-up at KIMS for 6–8 weeks after any severe CO poisoning episode.
- Prognostication must be multimodal (ERC/ESICM 2021)
- No single clinical, electrophysiological, biochemical, or imaging marker has sufficient accuracy to determine prognosis alone. Clinical examination, EEG and SSEP, NSE, and CT/MRI are combined, at least 72 hours after return to normothermia. Multiple concordant findings increase confidence; a single discordant finding indicating preserved function warrants caution, because the consequence of a wrong poor-outcome prediction is irreversible.
- 72-hour rule — no premature prognostication
- Neurological examination in the first 48 hours after cardiac arrest is confounded by: residual sedation/anaesthetic effects, metabolic abnormalities of the post-arrest state, and the direct neurological suppression of TTM itself. Premature withdrawal of care based on early examination has resulted in the deaths of patients who would have recovered. The KIMS prognostication assessment begins at 72 hours after return to normothermia (approximately 96–120 hours after arrest in TTM-treated patients).
- NSE and SSEP — the prognostic markers
- NSE (neuron-specific enolase): released from injured neurons. Levels >60 μg/L at 48–72 hours correlate with poor prognosis. Somatosensory evoked potentials (SSEPs): bilateral absence of the N20 cortical response at 72 hours = high specificity for poor prognosis. SSEPs are particularly valuable because they are largely unaffected by sedation (unlike clinical examination). Used together with EEG, CT/MRI, and clinical exam for multimodal prognostication.
- Avoid hyperoxia — target SpO₂ 94–98%
- After ROSC, 100% oxygen is NOT appropriate — hyperoxia worsens reperfusion injury by generating excess reactive oxygen species in already-damaged brain tissue. Target SpO₂ 94–98% and PaCO₂ 35–45 mmHg (normocapnia). Hypocapnia from hyperventilation causes cerebral vasoconstriction and reduces CBF, worsening ischaemia. Both hyperoxia and hypocapnia are iatrogenic secondary injuries that are entirely preventable.
| Fact | Details |
|---|---|
| Causes | Cardiac arrest with ROSC (most common) · Severe respiratory failure · Near-drowning · CO poisoning · Prolonged severe hypotension |
| Reperfusion paradox | Restoration of blood flow triggers second wave of injury · Excitotoxicity + free radicals + calcium influx + mitochondrial failure · Target of TTM |
| TTM | 33–36°C for 24 hours post-ROSC · Rewarming max 0.25°C/hour · Fever prevention 72 hours · Available at KIMS NICU with surface and endovascular cooling |
| CO poisoning | Pulse oximetry falsely normal (reads COHb as OHb) · ABG co-oximetry required · HBO for COHb >25% or coma · DNS in 10–30%: 2–4 weeks after apparent recovery · Globus pallidus T2 fingerprint |
| 72-hour rule | No prognostication until 72 hours after normothermia · Sedation + metabolic state confound early exam · Multimodal: clinical + EEG + SSEP + NSE + MRI |
| Prognostic markers | Prognostication is multimodal (ERC/ESICM 2021) — no single marker is sufficient alone · NSE >60 μg/L at 48–72h is associated with poor prognosis, with assay-dependent variability · Bilateral absent N20 SSEP = high specificity for poor prognosis (unaffected by sedation) · Combine clinical exam, EEG/SSEP, NSE and CT/MRI, at least 72h after normothermia · Discordant findings warrant caution |
| Avoid | Hyperoxia (SpO₂ >98%) worsens reperfusion injury · Hypocapnia reduces CBF · Fever: every degree worsens outcome |
About This Condition
Hypoxic Brain Injury at a Glance
The essential facts that shape how hypoxic brain injury is recognised and managed at KIMS — the primary precipitants from cardiac arrest through near-drowning and CO poisoning, the narrow 4–6 minute window of neuronal vulnerability, the central role of reperfusion injury as the second wave of damage, targeted temperature management as the most evidence-based neurointensive intervention, the 72-hour rule for multimodal neuroprognostication, brain death evaluation when appropriate, the long-arc neurorehabilitation that begins in the ICU, and the India context where bystander CPR remains the strongest modifiable predictor of good neurological outcome.
Primary cause
Cardiac arrest with CPR and ROSC · Also: severe respiratory failure, near-drowning, CO poisoning, severe sustained hypotension.
Brain vulnerability
Neurons begin to die after 4–6 minutes of complete oxygen deprivation · Partial hypoxia: duration and degree determine injury.
Reperfusion injury
Restoration of blood flow triggers secondary injury cascades (excitotoxicity, free radicals, calcium influx) · The post-ROSC period is as critical as the arrest itself.
Targeted temperature management (TTM)
Cooling to 33–36°C for 24 hours post-ROSC · Reduces cerebral metabolic demand · Reduces reperfusion injury · Improves neurological outcomes after cardiac arrest · Available at KIMS.
Neuroprognostication
At 72 hours after normothermia: clinical exam + EEG + SSEPs + NSE blood test + CT/MRI · Must be multimodal (ERC/ESICM 2021) — no single test is sufficient to determine prognosis on its own.
Brain death
Evaluation when appropriate: clinical criteria + apnoea test + confirmatory tests (EEG, CBFV) · Organ donation counselling.
Neurorehabilitation
Begins in ICU with early mobilisation · Continues inpatient then outpatient · Cognitive, motor, speech, behavioural rehabilitation.
India note
Witnessed cardiac arrests with immediate bystander CPR is the strongest modifiable predictor of good neurological outcome · Bystander CPR rates in India remain very low.
Hypoxic Brain Injury — Reduced Oxygen Delivery and the Reperfusion Paradox
Hypoxic brain injury occurs when the brain receives significantly reduced but not completely absent oxygen delivery for a period sufficient to cause neuronal injury. It is the most common form of acquired brain injury after cardiac arrest, and it is also seen after severe respiratory failure, near-drowning, carbon monoxide poisoning, and prolonged severe hypotension. The word "hypoxic" distinguishes it from "anoxic" (complete absence of oxygen) — although in practice the two terms are often used interchangeably, and the distinction matters more for prognosis than for acute management.
The central paradox of hypoxic brain injury is the phenomenon of reperfusion injury: when blood flow and oxygenation are restored (e.g. after return of spontaneous circulation following CPR), a cascade of harmful events is triggered — excitotoxicity (glutamate overflow damaging neurons), calcium influx, free radical production, and mitochondrial dysfunction — that can cause more brain damage than the original hypoxic event itself. This is why the post-resuscitation period is not simply a period of "recovery" — it is a critical window for active neuroprotective intervention.
Emergency / Consultation
Speak directly with the KIMS hypoxic brain injury team — all coordinated under one roof. Available 24 hours for acute presentations.
040-44885000Emergency line available 24 hoursMechanisms of Hypoxic Brain Injury
Three foundational principles that explain why hypoxic brain injury behaves the way it does at KIMS — the extreme oxygen dependence of neurons that makes the brain die within minutes, the paradoxical second wave of reperfusion injury that follows the return of blood flow, and the hidden cellular hypoxia of carbon monoxide poisoning that masquerades behind normal pulse oximetry.
The vulnerable brain — why neurons die so fast without oxygen
The brain accounts for only 2% of body weight but consumes approximately 20% of the body's oxygen supply. Neurons have almost no energy reserve — they depend on a continuous supply of oxygen and glucose to maintain the ion gradients (sodium outside, potassium inside, calcium outside) that are the basis of their electrical function. When oxygen is cut off, ATP production fails within seconds, ion pumps stop, cells depolarise uncontrollably, and glutamate floods the synapse. Glutamate activates NMDA receptors, allowing massive calcium influx into neurons — which activates destructive enzymes (calpains, phospholipases, nitric oxide synthase) and triggers apoptosis and necrosis. The hippocampus (memory) and the watershed zones of the cortex (between the anterior and middle cerebral artery territories) are most vulnerable.
Reperfusion injury — the second wave of damage
Paradoxically, restoration of blood flow after hypoxia triggers a second wave of injury. Reperfused neurons are flooded with oxygen, which reacts with accumulated free radicals to form reactive oxygen species (ROS) that oxidise lipid membranes, proteins, and DNA. Mitochondria, already damaged by the ischaemia, undergo permeability transition and release cytochrome C, triggering apoptosis in neurons that survived the initial hypoxic phase. This reperfusion injury is the target of therapeutic hypothermia (targeted temperature management): cooling the brain reduces metabolic demand, suppresses the inflammatory cascade, and limits reperfusion injury.
Carbon monoxide poisoning — the hidden hypoxic brain injury
Carbon monoxide (CO) is a colourless, odourless gas produced by incomplete combustion (generator exhaust, coal fires, vehicles in enclosed spaces). It binds to haemoglobin with 250 times the affinity of oxygen, producing carboxyhaemoglobin — haemoglobin that cannot carry oxygen. CO also binds to cytochrome oxidase in the mitochondria, directly blocking cellular respiration. The result is cellular hypoxia despite adequate lung function and normal blood pressure. Clinically: headache, dizziness, confusion, vomiting at low COHb levels; coma and cardiac arrest at high levels. Standard pulse oximetry is misleading in CO poisoning (it reads carboxyhaemoglobin as oxyhaemoglobin and gives a falsely normal reading). Diagnosis requires co-oximetry (ABG analyser). Treatment: 100% oxygen by non-rebreather mask · Hyperbaric oxygen (HBO) for severe cases (COHb >25%, coma, cardiac involvement) — dramatically accelerates CO elimination and reduces delayed neurological sequelae.
Treatment
Targeted Temperature Management at KIMS
The two pillars of temperature-directed neuroprotection after cardiac arrest at KIMS — the formal TTM protocol for eligible comatose post-ROSC patients with surface and endovascular cooling, and the parallel imperative of aggressive fever prevention for the first 72 hours where every degree of pyrexia worsens neurological outcomes.
TTM — the most evidence-based neurointensive care intervention after cardiac arrest
Targeted temperature management (TTM) — formerly called therapeutic hypothermia — is the deliberate cooling of a post-cardiac arrest patient's core body temperature to 33–36°C for 24 hours, followed by controlled rewarming (maximum 0.25°C/hour) and avoidance of fever for a further 48–72 hours. Evidence: TTM significantly improves neurological outcomes in patients resuscitated from out-of-hospital cardiac arrest with shockable rhythms (VF/VT) — and is applied in non-shockable rhythms (PEA/asystole) in many centres given the biological plausibility. Eligibility: comatose patients post-ROSC (GCS <8) without obvious contraindications (severe coagulopathy, active haemorrhage, haemodynamic instability unresponsive to resuscitation). At KIMS: surface cooling devices and endovascular cooling catheters are available for TTM in the neurointensive care unit.
Fever prevention after cardiac arrest — the 72-hour window
Even if formal TTM to 33–36°C is not applied, preventing fever (temperature above 37.5°C) for the first 72 hours after cardiac arrest is strongly recommended. Each degree of fever after cardiac arrest significantly worsens neurological outcomes by increasing cerebral metabolic demand and exacerbating excitotoxicity. Antipyretics (paracetamol) and physical cooling measures are used proactively.
Neuroprognostication After Cardiac Arrest at KIMS
Neurological prognosis after hypoxic brain injury is determined at KIMS through a deliberate, multimodal workflow that begins with the 72-hour rule (no prognostication until at least 72 hours after return to normothermia), then integrates clinical examination, continuous EEG, somatosensory evoked potentials, blood biomarkers, and CT/MRI imaging. No single test is definitive — the team weighs the results together to protect patients who would recover from premature withdrawal of care :
Multimodal prognostication — no single predictor is sufficient
Neuroprognostication after hypoxic-ischaemic brain injury must be multimodal: no single clinical, electrophysiological, biochemical, or imaging marker has sufficient accuracy to determine prognosis in isolation (ERC/ESICM 2021 Guidelines for Post-Resuscitation Care). Prognostication combines clinical examination (pupillary and corneal reflexes, motor response, myoclonic status epilepticus); electrophysiology (EEG background and reactivity, SSEP N20); biomarkers (NSE at 48–72 hours, with significant assay-dependent variability); and neuroimaging (CT grey-white ratio, MRI diffusion restriction). At least 72 hours should elapse after return to normothermia before formal prognostication. Multiple concordant findings from different modalities pointing toward poor outcome increase confidence; any discordant finding indicating preserved function warrants caution. This matters because sedation and therapeutic hypothermia temporarily confound clinical and electrophysiological markers, and because the consequence of incorrectly predicting a poor outcome — withdrawal of life-sustaining treatment in a potentially recoverable patient — is irreversible.
The 72-hour rule — why prognosis cannot be determined early
The neurological examination in the first 24–48 hours after cardiac arrest is confounded by: the effects of sedation and muscle relaxants used during resuscitation and ICU management · The metabolic abnormalities of the post-arrest state · The ongoing impact of TTM (hypothermia itself suppresses neurological function). Prognostication should not be attempted until at least 72 hours after return to normothermia (i.e. approximately 96–120 hours after the arrest in patients who received TTM). Premature withdrawal of care based on early neurological examination has led to deaths of patients who would have recovered.
Clinical examination
Absence of pupillary light reflex (bilaterally absent pupils at 72 hours = poor prognosis sign) · Absence of corneal reflexes · Presence or absence of motor response to pain · Myoclonic status epilepticus on clinical examination.
EEG — continuous electroencephalography
Suppressed-burst or flat EEG · Seizure activity on continuous EEG monitoring. Continuous EEG also detects non-convulsive seizures and informs prognostic background patterns.
Somatosensory evoked potentials (SSEPs)
Bilateral absence of the N20 cortical response = high specificity for poor prognosis. SSEPs are particularly valuable because they are largely unaffected by sedation.
Blood biomarkers — serum neuron-specific enolase (NSE)
Serum neuron-specific enolase (NSE) — levels above 60 μg/L at 48–72 hours correlate with poor prognosis. NSE is released from injured neurons and reflects the burden of neuronal damage.
CT and MRI imaging
Loss of grey-white differentiation on CT (global cerebral oedema sign) · Diffuse restriction on DWI-MRI in the cortical and deep grey matter. Imaging adds anatomical specificity to the multimodal prognostication picture.
Management at KIMS
The KIMS hypoxic brain injury programme is built around two integrated care areas — acute neurointensive care for prevention of secondary brain injury (airway and ventilation with avoidance of hyperoxia, MAP-directed haemodynamics, TTM with controlled rewarming and fever prevention, continuous EEG with aggressive seizure treatment, and tight glucose control), and a long-arc neurorehabilitation programme (early ICU mobilisation, cognitive rehabilitation, speech and language therapy, occupational therapy, neuropsychology, and family education from ICU through community reintegration).
Acute Neurointensive Care and Long-Arc Neurorehabilitation
Acute Phase — Neurointensive Care: The overarching principle in post-ROSC care: the primary hypoxic injury cannot be reversed, but secondary reperfusion injury can be limited by precise control of airway, haemodynamics, temperature, seizures, and glucose. The KIMS neurointensive care protocol integrates these targets in parallel from the moment of admission.
Airway: Mechanical ventilation · Target PaO₂ 94–98% (avoid hyperoxia — worsens reperfusion injury) · Target PaCO₂ 35–45 mmHg (normocapnia).
Haemodynamics: Target MAP ≥65 mmHg (or higher in the context of elevated ICP) · Vasopressors (norepinephrine) if needed · Avoid hypotension strenuously.
TTM: 33–36°C for 24 hours in eligible post-ROSC comatose patients · Controlled rewarming 0.25°C/hour · Fever prevention to 72 hours.
Seizure management: Continuous EEG monitoring · Treat seizures aggressively (levetiracetam, valproate, benzodiazepines for status epilepticus) · Consider prophylactic AED if high seizure risk.
Glucose: Tight glucose control (6–10 mmol/L) · Both hypoglycaemia and hyperglycaemia worsen neurological outcomes.
Neurorehabilitation — From ICU to Home: Early mobilisation in the ICU (passive ranging, sitting up, standing with physiotherapy support) · Cognitive rehabilitation for memory, attention, and executive function deficits · Speech and language therapy for dysarthria and dysphagia · Occupational therapy for ADL retraining · Neuropsychology for emotional and behavioural sequelae · Family education about the expected recovery trajectory.
Related Conditions
Hypoxic brain injury belongs to the family of acquired brain injuries evaluated and managed at KIMS Neuroscience. Explore related acquired-brain-injury conditions or return to the acquired brain injury hub.
FAQs
Frequently Asked Questions
A post-cardiac arrest patient needs more than a heartbeat — they need targeted temperature management, continuous EEG monitoring, multimodal neuroprognostication, and a rehabilitation programme that begins in the ICU.
At KIMS Hyderabad, the neurointensive care and neurorehabilitation teams provide this pathway from the moment of ROSC through to community reintegration. Emergency: 040-46324365. Outpatient rehabilitation: 040-44885000.
International enquiries: info@kimsneurosciences.com